EFAX ETF Analysis

Bu sayfa İngilizce aslından yapay zekâ ile çevrildi; İngilizce sürüm esastır. İngilizce sürümü oku

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir.

Kısa Cevap

EFAX ETF has a last stored price of $53.65, as of the Oct 2, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is ASML Holding NV (ASML.AS) at 2.74%.

EFAX ETF — Price, Holdings & Analysis

ETF Genel Bakış

EFAX aims to provide investors with a focused approach to international equity exposure. Unlike broad-based international ETFs that may hold hundreds or thousands of stocks, EFAX invests. This strategy allows for potentially higher returns if the selected companies outperform, but it also introduces greater risk due to the lack of diversification. The fund's holdings are primarily large-cap companies based in Europe and Asia, including ASML Holding NV (2.74%), Roche Holding AG (1.62%), and AstraZeneca PLC (1.57%). This concentrated approach may appeal to investors seeking targeted exposure to specific international companies, but it is important to consider the increased volatility associated with a less diversified portfolio. EFAX's strategy is distinct from market-cap weighted international ETFs, which typically offer broader diversification across a larger number of holdings.

Risk Metrikleri

EFAX's concentrated portfolio introduces significant concentration risk. A substantial portion of the fund's assets is allocated to a small number of companies, meaning that the performance of these companies will have a disproportionate impact on the fund's overall returns. The fund's beta of 1.02 indicates that it has a slightly higher volatility than the market. Investors should also consider the potential impact of currency fluctuations on the fund's returns, as the underlying holdings are denominated in various foreign currencies. Past performance does not guarantee future results.

Beta: 1.02

EFAX hangi varlıkları tutuyor?

Varlık	Ağırlık
ASML Holding NV (ASML.AS)	2.74%
Roche Holding AG (ROG.SW)	1.62%
AstraZeneca PLC (AZN.L)	1.57%
Novartis AG Registered Shares (NOVN.SW)	1.56%
HSBC Holdings PLC (HSBA.L)	1.56%
Nestle SA (NESN.SW)	1.36%
Toyota Motor Corp (7203.T)	1.13%
Siemens AG (SIE.DE)	1.07%
Mitsubishi UFJ Financial Group Inc (8306.T)	1.06%
SAP SE (SAP.DE)	1.02%

Varlıklar ve ağırlıklar 15 Mar 2026 itibarıyla. Bu fon verileri 45 günden eski; güncel varlıkları ihraççıdan doğrulayın.

Temettü Verimi

0.00%

Sorular & Cevaplar

What is EFAX and what does it track?

EFAX is an exchange-traded fund that provides concentrated exposure to a small selection of international equities. Unlike many ETFs that track broad market indexes, EFAX.

This focused approach aims to deliver potentially higher returns by concentrating investments in a select group of companies.

What are the top holdings in EFAX?

EFAX's top holdings include ASML Holding NV (2.74%), Roche Holding AG (1.62%), and AstraZeneca PLC (1.57%). These companies represent a significant portion of the fund's total assets.

The fund's concentration in these top holdings means that their individual performance will have a notable impact on the overall performance of EFAX. Investors should research these companies to understand their businesses and assess their potential for future growth.

Is EFAX a good long-term investment?

Whether EFAX is a suitable long-term investment depends on an individual investor's risk tolerance and investment objectives. The fund's concentrated portfolio introduces a higher level of risk compared to more diversified ETFs.

The fund's beta of 1.02 suggests it may be slightly more volatile than the overall market. Investors should carefully consider these factors and their own investment goals before investing in EFAX. Past performance does not guarantee future results.

How does EFAX compare to similar ETFs?

EFAX distinguishes itself from similar ETFs through its highly. Most international equity ETFs hold a much larger number of companies to achieve broader diversification. This concentrated approach can lead to higher potential returns but also greater volatility.

Without expense ratio information, it's difficult to compare the cost-effectiveness of EFAX to its peers.

Does EFAX pay dividends?

According to the provided data, EFAX has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders.

Investors seeking income from their investments may want to consider other ETFs with higher dividend yields. However, it is important to note that dividend yields can fluctuate over time and are not guaranteed.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Bu sayfayı makine yazdı, sayfa sayfa insan denetiminden geçmedi. Editoryal denetim sistemiktir: kurallar ve kaynaklar denetlenir, tek tek sayfalar denetlenmez.